Filip Dubovsky
Chief Tech/Sci/R&D Officer bei NOVAVAX, INC.
Vermögen: 318 410 $ am 31.03.2024
Profil
Derzeit hat Filip Dubovsky die Position des Chief Medical Officer & Executive Vice President bei Novavax, Inc. inne. Er ist außerdem Mitglied des Vorstands des Albert B. Sabin Vaccine Institute, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NOVAVAX, INC.
0,05% | 10.03.2024 | 66 613 ( 0,05% ) | 318 410 $ | 31.03.2024 |
Aktive Positionen von Filip Dubovsky
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVAVAX, INC. | Chief Tech/Sci/R&D Officer | 17.06.2020 |
Albert B. Sabin Vaccine Institute, Inc.
 Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Director/Board Member | - |
Ehemalige bekannte Positionen von Filip Dubovsky
| Unternehmen | Position | Ende |
|---|---|---|
| ASTRAZENECA PLC | Chief Tech/Sci/R&D Officer | 01.01.2020 |
Ausbildung von Filip Dubovsky
| The Johns Hopkins University | Undergraduate Degree |
| The University of Alabama | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| NOVAVAX, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Albert B. Sabin Vaccine Institute, Inc.
Albert B. Sabin Vaccine Institute, Inc. Miscellaneous Commercial ServicesCommercial Services Albert B. Sabin Vaccine Institute, Inc. creates solutions to health threats. It works with governments, leading public and private organizations, and academic institutions to provide solutions for some of the pervasive health care challenges. The company was founded in 1993 and is headquartered in Washington, DC. | Commercial Services |
